Skip to main content

Table 2 Clinical characteristics

From: Are treatment benefits in neuropathic pain reflected in the self assessment of treatment questionnaire?

  Total N = 44
Mean of Patients’ Onset of Neuropathic Pain Diagnosis in Years (SD) [Range] 7.5 (8.1) [1.0-40.0]
Type of Neuropathic Pain (n, %)  
 Postherpetic Neuralgia (PHN) 8 (18.2%)
 HIV-associated Neuropathy (HIV-AN) 16 (36.4%)
 Painful Diabetic Peripheral Neuropathy (PDPN) 20 (45.5%)
Mean of Patient’s Rating of Pain (SD) [Range] 6.9 (1.7) [3.0-10.0]
Frequency of Opioid Medication 1  
 Hydrocodone 5 (11.4%)
 Oxycodone 1(2.3%)
 Other2 9 (20.5%)
Frequency of Non-Opioid Medication 1  
 Pregabalin 13 (29.6%)
 Duloxetine 7 (15.9%)
 Gabapentin 27 (61.4%)
 Other3 24 (54.5%)
Frequency of Topical Medication 1  
 QUTENZATM 11 (25.0%)
 Lidocaine 3 (6.8%)
 Other4 2 (4.6%)
Mean Patient Height, feet (SD) [Range] 5.5 (0.4) [4.5-6.2]
Mean Patient Weight, pounds (SD) [Range] 196.7 (45.9) [108.0-315.0]
  1. 1These categories are not mutually exclusive.
  2. 2Other Opioid medications reported by participants included: Darvocet (n=1); MS Contin (n=1); Tramadol (n=6); Vicodin (n=1).
  3. 3Other Non-Opioid medications reported included: Advil (n=2); Aleve (n=1); Amitriptyline (n=3); Aspirin (n=2); Baclofen (n=1); Carbamalbpine (n=1); Celebrex (n=1); Cymbalta (n=1); Diclofenac (n=1); Glipizide (n=1); Motrin (n=1); Naproxen (n=2); Nortriptyline (n=1); Topamax (n=3); Tylenol (n=1); Tylenol Extra Strength (n=2).
  4. 4Other Topical medications reported by participants included: Amitriptyline 5%, Gabapentin 5%, Ketamine 8% (n=1); Zotrix 0.75 Cream (n=1).